Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Belinostat
Belinostat
866323-14-0
|
318.067
|
1.177
Belinostat is a novel agent that inhibits the enzyme histone deacetylase with a sulfonamide-hydroxamide structure. It is used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
(2E)-3-[3-(anilinosulfonyl)phenyl]-N-hydroxy-acrylamide | (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide | (E)-N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)acrylamide | Beleodaq | PDX-101 | PX105684 | PXD-101 | belinostat
Belinostat is a novel agent that inhibits the enzyme histone deacetylase with a sulfonamide-hydroxamide structure. It is used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
(2E)-3-[3-(anilinosulfonyl)phenyl]-N-hydroxy-acrylamide | (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide | (E)-N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)acrylamide | Beleodaq | PDX-101 | PX105684 | PXD-101 | belinostat
$80/5 mg
(EBC)
1
We provide 0 compound for Belinostat